XL413 hydrochloride is a potent, selective, ATP-competitive inhibitor of Cdc7, used to inhibit cell proliferation, reduce cell viability, induce caspase-3/7 activity, and suppress anchorage-independent growth in Colo-205 cells; it exhibits cytotoxic effects against tumor cells (particularly Colo-205), induces apoptosis in Colo-205 cells, and effectively inhibits DDK activity and DDK-dependent Mcm2 phosphorylation in vitro; it also demonstrates favorable pharmacokinetic properties and good tolerability in vivo.